Peptide HLA-A*02:01 Human Survivin LTLGEFLKL 1 mg
| Target | Cancer |
|---|---|
| Product Type | Peptide |
| Application | FCM |
| Class | Class I |
| Species Reactivity | Human |
| Allele | HLA-A*02:01 |
| Peptide Sequence | LTLGEFLKL |
| Research Area | Immunology, Immune Monitoring |
| Protocols | FCM |
| Specificity | Survivin |
| Formulation | Lyophilized |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
